Dynamic Multi-Analyte Testing Technology for Accelerated Biomarker Measurement Patrick van den Bogaard, Biocartis, speaking at Microarray World Congress 2012
Chromatin Remodeling and Epigenetic Control of Cell Differentiation Karl Ekwall, Karolinska Institute, speaking at Genomics Research Europe 2012
Detection of Rare Cancer Cell Phenotypes by Single Cell Analysis of Surface Proteins Rajan Kumar, Genome Data Systems, Inc., speaking at Lab-on-a-Chip World Congress 2012
The Use of -omic Technologies for Biomarker Development Michael Pfaffl, Principal Investigator, Technical University of Munich, speaking at Genomics Research Asia 2012
Epigenetic Characterization of the FMR1 Gene and Aberrant Neurodevelopment in Human Induced Pluripotent Stem Cell Models of Fragile X Syndrome Dr Steven Sheridan, Harvard Medical School, speaking at Stem Cells 2012
Kinase Centric Chemical Proteomics Provides Novel Insights into Individual Cancer Biology Bernhard Kuster, Technical University Munich, speaking at Systems Biology Europe 2012
An Integrated System Using Peptide Arrays to Assess Kinase and Nuclear Receptor Activities in Clinical Samples for Biomarker Development Bertrand Jordan, Aix-Marseille University, speaking at Microarray World Congress 2012
Signalling Molecules as Proteomic Biomarkers in Brain Tumours Radu Albulescu talking on behalf of Cristiana Tanase MD, PhD, Victor Babes University of Medicine and Pharmacy, Timisoara, speaking at Molecular Diagnostics Europe 2012.
Chemiluminescence-Based Biosensors for Point-of-Care Multiplex Sensing as a Companion Diagnostics in Personalized Medicine Professor Aldo Roda, University of Bologna, speaking at Advances in Biodetection and Biosensors 2012.